
About the Program

Infertility affects spproximately 17.5% of population and is recognized by the World Health Organization as a disease with a profound impact on quality of life. At the same time, birth rates are declining worldwide—between 2016 and 2021 by 9%, and since the 1950s fertility have dropped by about half, with major socioeconomic impact on society. In response to these trends, the importance of assisted reproduction (ART) is steadily increasing. Since 1978, more than 10 million children have been born with the help of ART, representing 7.9% of all children born in Europe and 5.1% in the United States in 2018. Today, ART is the most effective treatment for infertility, therefore it is essential to connect clinical practice with biological research to prepare new methods, which will be used for inferetility treatment.
ART for Future – the AV21 Strategy program responds to the challenges of declining fertility and the growing importance of assisted reproduction.
It integrates biological and medical research with ethical and legal aspects of ART.
The aim is to better understand embryonic development and its major pitfalls, to improve the ART methods, and at the same time ensure their safety for future generations.
We connect cutting-edge research with clinical practice and will actively contribute to shaping European legislation in reproductive medicine.






